Biliary Atresia Research Consortium (PROBE)

This study is currently recruiting participants.
Verified April 2012 by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sponsor:
Information provided by (Responsible Party):
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00061828
First received: June 5, 2003
Last updated: April 23, 2012
Last verified: April 2012
  Purpose

Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary Atresia Research Consortium (BARC) is to establish a database of clinical information and serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal hepatitis (INH) to facilitate research and to perform clinical, epidemiological and therapeutic trials in these two important pediatric liver diseases.


Condition
Biliary Atresia
Cholestasis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Prospective Database of Infants With Cholestasis

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Biospecimen Retention:   Samples With DNA

Samples of blood, urine and liver tissue samples will be collected for research purposes.


Estimated Enrollment: 1000
Study Start Date: May 2004
Groups/Cohorts
Biliary Atresia
Infants presenting with cholestasis who are diagnosed with biliary atresia.
Non-Biliary Atresia
Infants presenting with cholestasis without a diagnosis of biliary atresia.

  Eligibility

Ages Eligible for Study:   up to 6 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

This study population will be selected from the patient base of participating speciality care clinics.

Criteria
  • Age less or equal to 180 days at presentation to clinical site.
  • Clinically meaningful cholestasis due to primary hepatobiliary disease.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00061828

Locations
United States, California
Children's Hospital Los Angeles Recruiting
Los Angeles, California, United States, 90027
Contact: Catherine Goodhue, CPNP     323-361-4566     cgoodhue@chla.usc.edu    
Principal Investigator: Kasper Wang, MD            
University of California Recruiting
San Francisco, California, United States, 94143
Contact: Camille Langlois     415-476-1756     langloisc@peds.ucsf.edu    
Contact: Shannon Fleck     415-476-1539     flecks@peds.ucsf.edu    
Principal Investigator: Philip Rosenthal, MD            
United States, Colorado
Children's Hospital Colorado Recruiting
Aurora, Colorado, United States, 80045
Contact: Sheryl Faut     720-777-4691     sheryl.faut@childrenscolorado.org    
Contact: Michelle Hite     720-777-4690     michelle.hite@childrenscolorado.org    
Principal Investigator: Ronald Sokol, MD            
Sub-Investigator: Cara Mack, MD            
Sub-Investigator: Michael Narkewicz, MD            
United States, Georgia
Children's Healthcare of Atlanta (Emory University) Recruiting
Atlanta, Georgia, United States, 30322
Contact: Sundari Sekar, MBBS, DGO     404-785-1467     sundari.sekar@choa.org    
Contact: jessica huamani     404-785-2200     jessica.huamani@choa.org    
Principal Investigator: Saul Karpen, MD, PhD            
United States, Illinois
Children's Memorial Hospital Recruiting
Chicago, Illinois, United States, 60614
Contact: Sue Kelly, RN, BSN     773-868-8931     skelly@childrensmemorial.org    
Contact: Elizabeth Westfall     773-975-8523     ewestfall@childrensmemorial.org    
Principal Investigator: Peter Whitington, MD            
United States, Indiana
Riley Hospital for Children Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Beth RN Byam, RN     317-944-3774     ebyam@iupui.edu    
Contact: Ann Klipsch, RN     317-944-9605     aeye@iupui.edu    
Principal Investigator: Jean Molleston, MD            
United States, Maryland
Johns Hopkins School of Medicine Recruiting
Baltimore, Maryland, United States, 21287
Contact: Anitha Devadason     410-955-1736     cdevada2@jhmi.edu    
Contact: Kim Pfeifer, RN, BSN     410-614-8583     kfehily2@jhmi.edu    
Principal Investigator: Kathleen Schwarz, MD            
United States, Missouri
Washington University School of Medicine Recruiting
St Louis, Missouri, United States, 63110
Contact: Kathleen Harris     314-747-5708     harris_k@kids.wustl.edu    
Contact: Stacy Postma     314-747-5931     postma_s@kids.wustl.edu    
Principal Investigator: Yumi Turmelle, MD            
United States, New York
Mount Sinai Medical Center Recruiting
New York City, New York, United States, 10029
Contact: Nacole Brown     212-659-8046     nacole.brown@mountsinai.org    
Principal Investigator: Nanda Kerkar Kerkar, MD            
United States, Ohio
Children's Hospital Medical Center Recruiting
Cincinnati, Ohio, United States, 45229
Contact: Jan Dietz     513-636-7266     jan.dietz@cchmc.org    
Contact: Kathleen Deal     513 636 7818     kathleen.deal@cchmc.org    
Principal Investigator: Jorge Bezerra, MD            
Sub-Investigator: John Bucuvalas, MD            
United States, Pennsylvania
Children's Hospital of Philadelphia Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Jessi MPH Erlichman, MPH     215-590-2525     erlichman@email.chop.edu    
Contact: Oyinkansola Kusemiju, MPH     267-426-0970     kusemijuo@email.chop.edu    
Principal Investigator: Kathleen Loomes, Loomes, MD            
Sub-Investigator: Elizabeth Rand, MD            
Children's Hospital of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Beverly Bernard, CRNP     412-692-5811     beverly.bernard@chp.edu    
Contact: Kathy Bukauskas, RN     412-692-7734     kathryn.bukauskas@chp.edu    
Principal Investigator: Benjamin Shneider, MD            
Sub-Investigator: Robert Squires, Jr, MD            
Sub-Investigator: David Perlmutter, MD            
United States, Texas
Baylor College of Medicine Active, not recruiting
Houston,, Texas, United States, 77030
United States, Washington
Seattle Children's Hospital Recruiting
Seattle, Washington, United States, 98105
Contact: Melissa Young     206-987-1037     melissa.young@seattlechildrens.org    
Principal Investigator: Karen Murray, MD            
Canada, Ontario
The Hospital for Sick Children Recruiting
Toronto, Ontario, Canada, M5G 1X8
Contact: Allison Chiu     416-813-7654 ext 1594     allison.chiu@sickkids.ca    
Contact: Ann Fu     416-813-7654 ext 1594     ann.fu@sickkids.ca    
Principal Investigator: Vicky Ng, MD            
Sponsors and Collaborators
Investigators
Study Chair: Ronald Sokol, MD Children's Hospital Colorado
Study Director: Ed Doo, MD National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator: John Magee, MD University of Michigan Medical Center, Ann Arbor
  More Information

Additional Information:
No publications provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00061828     History of Changes
Other Study ID Numbers: BARC - IND, U01-DK62456-01
Study First Received: June 5, 2003
Last Updated: April 23, 2012
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Biliary Atresia
Cholestasis
Bile Duct Diseases
Biliary Tract Diseases
Digestive System Diseases
Digestive System Abnormalities
Congenital Abnormalities

ClinicalTrials.gov processed this record on May 23, 2013